Precision Cancer Research: Omics, AI, CRISPR Advances
Received Date: Jul 01, 2025 / Accepted Date: Jul 29, 2025 / Published Date: Jul 29, 2025
Abstract
Recent advancements in cancer research highlight critical areas within precision oncology, spanning genomic, epigenetic, and
multi-omic approaches. Studies delve into somatic mutations, tumor evolution, and the complex tumor microenvironment, further
enhanced by technologies such as \textit{Artificial Intelligence} (AI), Single-cell RNA sequencing (scRNA-seq), and CRISPR
Cas9. Efforts are concentrated on improving early detection, understanding drug resistance, and developing personalized treatment
strategies. This comprehensive body of work collectively deepens our understanding of cancer biology, facilitating the identification
of novel therapeutic targets and clinical applications.
Keywords:
Citation: Hamilton S (2025) Precision Cancer Research: Omics, AI, CRISPR Advances. jcd 09: 310. Doi: 10.4172/2476-2253.1000310
Copyright: © 2025 Sarah Hamilton This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Select your language of interest to view the total content in your interested language
Share This Article
Recommended Journals
Open Access Journals
Article Tools
Article Usage
- Total views: 390
- [From(publication date): 0-0 - Apr 15, 2026]
- Breakdown by view type
- HTML page views: 315
- PDF downloads: 75
